Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomiki Sumiyoshi

Showing results (1-10 of 242) with videos related to

Pageof 25
Sort By:
Handbook of Experimental Pharmacology|May 16, 2015
Verbal memoryTomiki Sumiyoshi
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|July 28, 2012
[Essentials of neurocognitive assessment in clinical research]Tomiki Sumiyoshi
Frontiers in Pharmacology|August 30, 2013
Antipsychotic treatments; focus on lurasidoneTomiki Sumiyoshi
Expert Review of Clinical Pharmacology|January 14, 2014
Possible dose-side effect relationship of antipsychotic drugs: relevance to cognitive function in schizophreniaTomiki Sumiyoshi
Journal of Clinical Psychopharmacology|April 11, 2014
Serotonin(1A) receptors in the action of aripiprazoleTomiki Sumiyoshi
Journal of Psychopharmacology (Oxford, England)|August 3, 2012
Serotonin 1A receptors in the action of antipsychotic drugs: comment on 'Measurement of the serotonin 1A receptor availability in patients with schizophrenia during treatment with the antipsychotic medication ziprasidone' by Frankle et al. 2011; 25(6): 734-743Tomiki Sumiyoshi
Schizophrenia Research|October 26, 2019
Cognitive enhancement in schizophrenia by buspirone: Role of serotonin<sub>1A</sub> receptor agonismTomiki Sumiyoshi
Journal of Personalized Medicine|December 24, 2021
Psychoneurobiology Research and Personalized Treatment of SchizophreniaTomiki Sumiyoshi
Frontiers in Psychiatry|June 29, 2018
Electrophysiological Evidence in Schizophrenia in Relation to Treatment ResponseKazuki Sueyoshi, Tomiki Sumiyoshi
Frontiers in Behavioral Neuroscience|January 8, 2015
Cognitive deficits in schizophrenia and other neuropsychiatric disorders: convergence of preclinical and clinical evidenceAles Stuchlik, Tomiki Sumiyoshi
Pageof 25

Showing results (1-10 of 242) with videos related to

Sort By:
Pageof 25
Handbook of Experimental Pharmacology|May 16, 2015
Verbal memoryTomiki Sumiyoshi
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|July 28, 2012
[Essentials of neurocognitive assessment in clinical research]Tomiki Sumiyoshi
Frontiers in Pharmacology|August 30, 2013
Antipsychotic treatments; focus on lurasidoneTomiki Sumiyoshi
Expert Review of Clinical Pharmacology|January 14, 2014
Possible dose-side effect relationship of antipsychotic drugs: relevance to cognitive function in schizophreniaTomiki Sumiyoshi
Journal of Clinical Psychopharmacology|April 11, 2014
Serotonin(1A) receptors in the action of aripiprazoleTomiki Sumiyoshi
Journal of Psychopharmacology (Oxford, England)|August 3, 2012
Serotonin 1A receptors in the action of antipsychotic drugs: comment on 'Measurement of the serotonin 1A receptor availability in patients with schizophrenia during treatment with the antipsychotic medication ziprasidone' by Frankle et al. 2011; 25(6): 734-743Tomiki Sumiyoshi
Schizophrenia Research|October 26, 2019
Cognitive enhancement in schizophrenia by buspirone: Role of serotonin<sub>1A</sub> receptor agonismTomiki Sumiyoshi
Journal of Personalized Medicine|December 24, 2021
Psychoneurobiology Research and Personalized Treatment of SchizophreniaTomiki Sumiyoshi
Frontiers in Psychiatry|June 29, 2018
Electrophysiological Evidence in Schizophrenia in Relation to Treatment ResponseKazuki Sueyoshi, Tomiki Sumiyoshi
Frontiers in Behavioral Neuroscience|January 8, 2015
Cognitive deficits in schizophrenia and other neuropsychiatric disorders: convergence of preclinical and clinical evidenceAles Stuchlik, Tomiki Sumiyoshi
Pageof 25